VEDUShchIE ENDOKRINOLOGI OBSUDILI MESTO NOVOGO PREPARATA FORSIGA™ V LEChENII SAKhARNOGO DIABETA 2 TIPA
- Authors: - -
- Issue: No 16 (2014)
- Pages: 11-12
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287402
- ID: 287402
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
References
- Инструкция по медицинскому применению лекарственного препарата Форсига™ (таблетки, покрытые пленочной оболочкой, 5 и 10 мг). Регистрационное удостоверение ЛС - 002596 от 21.08.2014.
- DF Diabetes Atlas. 6th ed. 2013.
- Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290( 14):1884-90.
- Langkilde A.M., et al. Presented at the 49th Annual Meeting of the EASD, Barcelona, Spain, 23-27 September, 2013:Abstract 936.
- www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002322/human_med_001546.jsp&mid
- www.fda.gov/newsevents/newsroom/pressannouncements/ucm380829.htm
Supplementary files
![](/img/style/loading.gif)